Insider Trading & Ownership - Foster Robert T

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Foster Robert T
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-18
Purchase
2023-09-19
09:01 am
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO and Director
1,600$5.6$8,96050,470
(Direct)
View
2023-09-15
Purchase
2023-09-18
08:00 am
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO,CSO and Director
1,600$5.4$8,64048,870
(Direct)
View
2021-02-18
Purchase
2021-02-18
4:05 pm
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO and Director
20,000$2$40,00045,259
(Direct)
View
2020-12-08
Purchase
2020-12-08
1:56 pm
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO and Director
25,000$1.5767$39,41825,259
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-09-21
Option Award
2023-09-22
4:36 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHFoster Robert T
Director
53,283$053,283
(Direct)
View
2021-05-18
Option Award
2021-05-20
4:36 pm
N/A
2031-05-18
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO, CSO and Director
1,900,000$02,501,879
(Direct)
View
2020-08-19
Option Award
2020-08-21
4:17 pm
N/A
2030-08-19
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO,CSO and Director
212,000$0601,879
(Direct)
View
2020-04-03
Option Award
2020-04-07
4:13 pm
N/A
2030-04-03
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO and CSO
380,000$0389,879
(Direct)
View
2019-07-24
Option Award
2019-07-25
4:15 pm
N/A
2029-07-24
Hepion Pharmaceuticals Inc.HEPAFoster Robert T
CEO and CSO
9,700$09,879
(Direct)
View